THNR - Amplify Weight Loss Drug & Treatment ETF ETF Analysis | Stock Taper
Logo

THNR

Amplify Weight Loss Drug & Treatment ETF
Amplify Weight Loss Drug & Treatment ETF Amplify
$26.12 -0.22% (-0.06)

Managing Company Amplify
Asset Under Management $3.91M
Inception Date May 21, 2024
Expense Ratio 0.59%
52w High $26.44
52w Low $18.56
Volume 1,989
Avg Volume 2,048
Asset Class Equity

About Amplify Weight Loss Drug & Treatment ETF

THNR provides access to global companies expected to economically benefit from weight loss drug development. THNR seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index.